How severe is CVE-2025-12288?

CVE-2025-12288 has a CVSS 3.x base score of 4.3, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity none, and availability none.

Is CVE-2025-12288 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (35th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2025-12288?

CVE-2025-12288 affects Bdtask Pharmacare. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2025-12288?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

Does CVE-2025-12288 have an EU (EUVD) identifier?

Yes. CVE-2025-12288 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-36183.

When was CVE-2025-12288 published?

CVE-2025-12288 was published on 2025-10-27 and last updated on 2026-06-17.

CVE-2025-12288

CVE-2025-12288 is a medium-severity vulnerability in Bdtask Pharmacare with a CVSS 3.x base score of 4.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-639.

Key facts

Severity: Medium (CVSS 3.x base score 4.3)
CVSS v2: 4.0
CVSS v4: 2.1
EPSS exploit prediction: 0% (35th percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2025-36183
Weakness: CWE-639
Affected product: Bdtask Pharmacare
Published: 2025-10-27
Last modified: 2026-06-17

Description

A vulnerability was detected in Bdtask Pharmacy Management System up to 9.4. Affected is an unknown function of the file /user/edit_user/ of the component User Profile Handler. Performing manipulation results in authorization bypass. Remote exploitation of the attack is possible. The exploit is now public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.

Frequently asked questions

What is CVE-2025-12288?: A vulnerability was detected in Bdtask Pharmacy Management System up to 9.4. Affected is an unknown function of the file /user/edit_user/ of the component User Profile Handler. Performing manipulation results in authorization bypass. Remote exploitation of the attack is possible. The exploit is now public and may be used. The vendor was contacted early about this disclosure but did not respond in any way.
How severe is CVE-2025-12288?: CVE-2025-12288 has a CVSS 3.x base score of 4.3, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity none, and availability none.
Is CVE-2025-12288 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (35th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2025-12288?: CVE-2025-12288 affects Bdtask Pharmacare. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2025-12288?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2025-12288 have an EU (EUVD) identifier?: Yes. CVE-2025-12288 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2025-36183.
When was CVE-2025-12288 published?: CVE-2025-12288 was published on 2025-10-27 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:bdtask:pharmacare:*:*:*:*:*:*:*:*

Other CWE-639 (Authorization Bypass Through User-Controlled Key (IDOR)) vulnerabilities

CVE-2025-40805 — Critical (CVSS 10.0): Affected devices do not properly enforce user authentication on specific API endpoints. This could facilitate an…
CVE-2024-45032 — Critical (CVSS 10.0): A vulnerability has been identified in Industrial Edge Management Pro (All versions < V1.9.5), Industrial Edge…
CVE-2026-34037 — Critical (CVSS 9.9): Coolify is an open-source and self-hostable tool for managing servers, applications, and databases. Prior to…
CVE-2026-52782 — Critical (CVSS 9.9): OpenProject is open-source, web-based project management software. Prior to 17.3.3 and 17.4.1, there is an IDOR through…
CVE-2026-45552 — Critical (CVSS 9.9): Roxy-WI is a web interface for managing Haproxy, Nginx, Apache and Keepalived servers. In versions 8.2.6.4 and prior,…
CVE-2026-29200 — Critical (CVSS 9.9): A critical IDOR vulnerability has been discovered in Comet Backup affecting all versions from 20.11.0 to 26.1.1 and…

Browse all CWE-639 (Authorization Bypass Through User-Controlled Key (IDOR)) vulnerabilities →